The activation of PPARγ enhances Treg responses through up-regulating CD36/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TβRII/IL-2RαYumeng Miao, Zhifeng Wei, Yuxiao Hu et al.|Cell Communication and Signaling|2022Cited by 107
Morin, the PPARγ agonist, inhibits Th17 differentiation by limiting fatty acid synthesis in collagen-induced arthritisYumeng Miao, Zhifeng Wei, Xiaoqian Wu et al.|Cell Biology and Toxicology|2022Cited by 29
HSP90β shapes the fate of Th17 cells with the help of glycolysis‐controlled methylation modificationLing Yang, Zhifeng Wei, Jing‐Chao Zhu et al.|British Journal of Pharmacology|2024Cited by 9
PPARγ is a potential therapeutic target for radiation enteritis via suppressing ferroptosis, mediated by the GAPDH/glycosylation axisXi Zeng, Zhifeng Wei, Yue Dai et al.|British Journal of Pharmacology|2025Cited by 3